Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100

Medtronic PLC 10-K filed Jun 18, 2026

Fiscal year 2026 · Period ended Apr 24, 2026 · Filed · accepted 4:27 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business, against the 10-K filed Jun 20, 2025: 7 added · 7 removed · 49 modified; 2 with only figures updated

  1. Modified

    •Turn data, artificial intelligence (AI), and automation into action: We are confident in our ability to maximize new technology, AI, and data and analytics to tailor therapies in real-time, facilitating remote monitoring and care delivery that conveniently manages conditions, and creates new standards of care.

62 more changes in this Item, word by word, in Powerpack.

Powerpack